Off-label treatment of atopic dermatitis and psoriasis

Off-label treatment is widely used in the management of both atopic dermatitis and psoriasis. Real-world evidence plays a crucial role in guiding clinical practice and should be leveraged to support the more evidence-based implementation of off-label therapies.

Authors

Institutions

Publication Details

Journal
Journal of Dermatological Treatment
Published
2026-02-05
DOI
https://doi.org/10.1080/09546634.2026.2617768
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Off-label treatment of atopic dermatitis and psoriasis

Roman J. Nowicki, Leszek Bieniaszewski, Dorota Purzycka-Bohdan, Julia Sternicka-Rohde
Journal of Dermatological Treatment
Pharmaceutical studies and practices
article

Off-label treatment of atopic dermatitis and psoriasis

Roman J. Nowicki, Leszek Bieniaszewski, Dorota Purzycka-Bohdan, Julia Sternicka-Rohde
article en

Abstract

Off-label treatment is widely used in the management of both atopic dermatitis and psoriasis. Real-world evidence plays a crucial role in guiding clinical practice and should be leveraged to support the more evidence-based implementation of off-label therapies.

Journal of Dermatological TreatmentVol. 37(1)
University Dermatology (US), Gdańsk Medical University (PL)
Good health and well-being
Openalex Percentile: Top 65%
Pharmaceutical studies and practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.